GlassScriptPhysician profile
Anthony G Weber
NPI 1477909919
$3,410.74
in general payments reported to CMS, 2019-2025
21 companies · $827 in 2025
The $827 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $23.06 · 2021: $309 · 2022: $1,519 · 2023: $688 · 2024: $45.62 · 2025: $827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,326 · Travel and Lodging: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,326.27 |
| Travel and Lodging | $233.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,328.43 | 2022-2023 | Rotapro |
| Terumo Medical Corporation | $578.67 | 2022-2024 | Glidesheath Slender, Angio-Seal, Glidewire |
| Stryker Corporation | $254.42 | 2025 | Artix Mt, Flowtriever |
| Abbott Laboratories | $222.99 | 2021-2025 | Navitor, Xience Skypoint |
| Medtronic, INC. | $173.50 | 2022-2023 | Corevalve Evolut R |
| Abiomed | $131.68 | 2023-2025 | Impella |
| Janssen Pharmaceuticals, INC | $111.70 | 2021 | |
| Edwards Lifesciences Corporation | $102.37 | 2025 | Sapien 3 Ultra Resilia |
| Shockwave Medical, INC | $88.56 | 2025 | |
| Pfizer INC. | $83.17 | 2025 | |
| Amgen INC. | $66.54 | 2025 | Repatha, Repatha |
| Bridgebio Pharma, INC. | $62.33 | 2025 | Attruby |
| Lantheus Medical Imaging, INC. | $55.01 | 2020-2021 | |
| Cordis US Corp. | $31.77 | 2025 | Mynx Control Venous |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.33 | 2025 | Jardiance |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $21.14 | 2025 | Eliquis |
| Livanova USA, INC. | $19.14 | 2023 | Lifesparc |
| W. L. Gore & Associates, INC. | $13.80 | 2023 | Gore Cardioform Septal Occluder |
| Cardiva Medical, INC. | $12.66 | 2022 | |
| Novartis Pharmaceuticals Corporation | $12.29 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.24 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.